Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding.
about
Identification of the binding sites of the SR49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensorsInvestigation of Elemental Mass Spectrometry in Pharmacology for Peptide Quantitation at Femtomolar LevelsThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThe action of fish peptide Orpotrin analogs on microcirculation.Conformational changes of G protein-coupled receptors during their activation by agonist binding.Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies.Structural Elements in the Gαs and Gαq C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling.Identification of antagonists to the vasotocin receptor sub-type 4 (VT4R) involved in stress by molecular modelling and verification using anterior pituitary cells.Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein.Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study.Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor.Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands.Thiol antioxidants regulate angiotensin II AT1 and arginine vasopressin V1 receptor functions differently in vascular smooth muscle cells.A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors.A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors
P2860
Q28187967-4DE2B229-6AE0-463C-A426-904BADFEF70EQ28552043-548EA13D-1F2D-47EC-A8F1-68EEA9BB3D2BQ30486707-BB64AA74-0204-4D14-A094-DF8189751F99Q33817218-65778C39-858B-4747-90B7-0E3EABE9A008Q35588397-0CBF39AF-FD36-408B-8504-E292E1587161Q37265054-AC06EE90-7D6D-4166-B5B2-2F1F80D78BDCQ38762896-144807AD-B04F-4DB3-9887-6451FC3393DFQ39976073-C9898DC4-F219-4B58-B1E6-A7ED2C31C1F7Q40256331-EC108405-52EA-4D6B-B955-D137004564BAQ43438262-7CFEDCA9-BD12-4279-8E37-F041D0490DF8Q43597898-93FF3BC4-2427-45CC-9EDB-3B3BE21B925DQ45099209-850F5929-32F7-458D-BBDD-B063180475CCQ46224925-11BCF607-1A54-4D8E-82F9-A877B81ABD6AQ48042725-555D5496-8133-4B3A-B2EE-DA21B1F938D3Q58465767-5D626AFE-4CD9-4453-90FF-ABE9E1E88005
P2860
Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Conserved aromatic residues in ...... vs. antagonist ligand binding.
@ast
Conserved aromatic residues in ...... vs. antagonist ligand binding.
@en
type
label
Conserved aromatic residues in ...... vs. antagonist ligand binding.
@ast
Conserved aromatic residues in ...... vs. antagonist ligand binding.
@en
prefLabel
Conserved aromatic residues in ...... vs. antagonist ligand binding.
@ast
Conserved aromatic residues in ...... vs. antagonist ligand binding.
@en
P2093
P2860
P921
P1433
P1476
Conserved aromatic residues in ...... vs. antagonist ligand binding.
@en
P2093
B Mouillac
C Barberis
M N Balestre
S Phalipou
P2860
P304
P356
10.1046/J.1432-1033.2000.01472.X
P407
P577
2000-07-01T00:00:00Z